Acrodermatitis enterohepatica
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [2] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.
Overview
Acrodermatitis enteropathica occurs in two forms: an autosomal recessive inherited form and an acquired form. The congenital form of AE is a rare genetic disorder characterized by an inborn defect in the gastrointestinal absorption of zinc. Manifestations of the disease typically present when the affected infant is weaned from breast feeding. The acquired form is due to nutritional zinc deficiency, e.g. in premature infants who receive prolonged parenteral alimentation. The characteristic skin lesions include a periorificial and acral vesiculobullous eruption leading to scaley, sharply demarcated crusted plaques. In the acute phase, irritability and emotional disturbances are evident due to wasting (atrophy) of the brain cortex.
Other names include Acrodermatitis enteropathica, Acrodermatitis enteropathica syndrome, Brandt syndrome, Brandt's syndrome, Danbolt - Close syndrome, Danbolt syndrome, Danbolt-Closs syndrome, Danbolt's syndrome, Hereditary acrodermatitis enterohepatica, Primary zinc malabsorption, Primary zinc malabsorption syndrome, Syndrome, Brandt's, Syndrome, Danbolt, Syndrome, Danbolt-Closs